中红医疗 reported revenue of ¥1.48B for the period ended 2026-06-30, +19.5% year on year. Net income was ¥0.16B, a 10.7% net margin on a 24.0% gross margin. The largest revenue line is 健康防护产品 at 91% of the total. Free cash flow for the period was ¥0.15B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.48B | +19.5% |
| Gross profit | ¥0.35B | — |
| Operating income | ¥0.18B | — |
| Net income | ¥0.16B | +3694.2% |
| Gross margin | 24.0% | Net margin 10.7% |
| Revenue Q/Q | +45.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 健康防护产品 | ¥1.35B | 91.5% |
| 安全注输产品 | ¥0.07B | 5.0% |
| 创新孵化产品 | ¥0.05B | 3.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.12B | 76.0% |
| R&D | ¥0.03B | 1.7% |
| SG&A | ¥0.11B | 7.6% |
| Tax & other | ¥0.02B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | ¥7.69B |
| Total liabilities | ¥2.27B |
| Shareholders' equity | ¥5.42B |
| Equity / assets | 70.5% |
| Operating cash flow | ¥0.15B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.15B |
| Cash conversion (OCF / net income) | 133% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
苏文电能 ・ 尤安设计 ・ 金沃股份 ・ 致远新能 ・ 志特新材 ・ 川网传媒 ・ 津荣天宇 ・ 蕾奥规划 ・ 同飞股份 ・ 创益通 ・ 泰福泵业 ・ 玉马科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies